Higher levels of RBP4 are reportedly associated with an increased risk of sarcopenia, and RBP4 negatively correlates with sarcopenic measurements among Chinese older adults, suggesting its role as a potential biomarker of sarcopenia [81]. This evidence concerns the gene RBP4 and sarcopenia.